Frank van Leth

Associate Professor Health Sciences

Differential CD4 T‐cell response in HIV‐1‐infected patients using protease inhibitor‐based or nevirapine‐based highly active antiretroviral therapy


Journal article


F. van Leth, F. Wit, P. Reiss, J. Schattenkerk, M. Van Der Ende, Mme Schneider, J. Mulder, P. Frissen, F. de Wolf, J. Lange
HIV Medicine, 2004

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
van Leth, F., Wit, F., Reiss, P., Schattenkerk, J., Ende, M. V. D., Schneider, M., … Lange, J. (2004). Differential CD4 T‐cell response in HIV‐1‐infected patients using protease inhibitor‐based or nevirapine‐based highly active antiretroviral therapy. HIV Medicine.


Chicago/Turabian   Click to copy
Leth, F. van, F. Wit, P. Reiss, J. Schattenkerk, M. Van Der Ende, Mme Schneider, J. Mulder, P. Frissen, F. de Wolf, and J. Lange. “Differential CD4 T‐Cell Response in HIV‐1‐Infected Patients Using Protease Inhibitor‐Based or Nevirapine‐Based Highly Active Antiretroviral Therapy.” HIV Medicine (2004).


MLA   Click to copy
van Leth, F., et al. “Differential CD4 T‐Cell Response in HIV‐1‐Infected Patients Using Protease Inhibitor‐Based or Nevirapine‐Based Highly Active Antiretroviral Therapy.” HIV Medicine, 2004.


BibTeX   Click to copy

@article{f2004a,
  title = {Differential CD4 T‐cell response in HIV‐1‐infected patients using protease inhibitor‐based or nevirapine‐based highly active antiretroviral therapy},
  year = {2004},
  journal = {HIV Medicine},
  author = {van Leth, F. and Wit, F. and Reiss, P. and Schattenkerk, J. and Ende, M. Van Der and Schneider, Mme and Mulder, J. and Frissen, P. and de Wolf, F. and Lange, J.}
}